The Muscular Dystrophy Association is the world's leading nonprofit health agency dedicated to finding treatments and cures for muscular dystrophy, amyotrophic lateral sclerosis (ALS), and other neuromuscular diseases. It advances this mission by funding worldwide research; by providing comprehensive health care services and support to MDA families nationwide; and by rallying communities to fight back through advocacy, fundraising, and local engagement.
To that end, the organization is accepting Letters of Intent for its bi-annual Research Grants program, which awards grants to established investigators in support of projects aimed at developing treatments for muscular dystrophies and related diseases of the neuromuscular system. Awards are typically in the amount of $100,000 per year for one to three years.
To be eligible, an applicant must hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.), Doctor of Science (D.Sc.) or equivalent degree (i.e. D.O.); be a professional or faculty member (professor, associate professor, or assistant professor) at an appropriate educational, medical or, research institution; be qualified to conduct and mentor a program of original research within his or her own laboratory; assume both administrative and financial responsibility for the grant; and have access to institutional resources necessary to conduct the proposed research project.
Proposals from applicants outside the United States will be considered for projects of the highest priority to MDA and when, in addition to the applicant's having met the requirements noted above, the applicant may not have adequate sources of financial support for his/her research.
Letters of Intent must be received no later than June 15, 2017. Upon review, selected applicants will be invited to submit a full proposal by July 15, 2017.
See the MDA website for complete program guidelines, a list of currently funded projects, tips on how to develop a successful application, and application instructions.